Aptimmune Biologics Partners with Kemin Industries

Carrie Muehling

Aptimmune Biologics and Kemin Industries have formed a partnership in the global vaccine industry. As of July 31, 2018, Kemin is now an equity shareholder in Aptimmune and has exclusive rights to its vaccines and vaccine technologies outside the U.S. As part of the Kemin-Aptimmune partnership, the companies have formed Kemin Biologics, which will manufacture and market Aptimmune’s proprietary Barricade™ …

AgWired Animal, Animal Agriculture, Animal Health, Aptimmune, Swine

Outsmarting the PRRS Virus

Carrie Muehling

The 2018 Aptimmune Scientific Symposium focused on the success of the Barricade vaccine for porcine reproductive and respiratory syndrome (PRRS), which was introduced in 2017. “PRRS is a daunting challenge and a difficult vaccine to not only develop but also manage in the production world,” said Dr. Bob Nordgren, chairman of the board for Aptimmune. “For 20 years, we’ve come …

AgWired Animal, Animal Agriculture, Aptimmune, Audio

Aptimmune Vaccines Gaining Popularity

Carrie Muehling

Aptimmune is looking to grow its presence in the swine vaccine market with the success of Barricade for porcine reproductive & respiratory syndrome (PRRS). “It’s kind of an exciting time because we launched the product over a year ago and we’ve got customers that are using the product, evaluating it in a number of trials,” said Steve Berger, director of …

AgWired Animal, Animal Agriculture, Aptimmune, Audio, Swine

Aptimmune Shares Barricade Vaccine Field Data

Carrie Muehling

In the year since Aptimmune launched the Barricade vaccine to fight porcine reproductive & respiratory syndrome (PRRS), the company has been gathering field data from 30 different veterinarians in 12 different states. “We’ve been able to see a 50 percent reduction in mortality across the board, so it’s been very rewarding,” said Dr. Jessica Seate, professional service veterinarian for Aptimmune. …

AgWired Animal, Animal Agriculture, Aptimmune, Audio, Swine